Campbell & CO Investment Adviser LLC bought a new stake in Omega Healthcare Investors, Inc. (NYSE:OHI) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor bought 9,491 shares of the real estate investment trust’s stock, valued at approximately $313,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of OHI. Vanguard Group Inc. boosted its position in shares of Omega Healthcare Investors by 4.6% in the first quarter. Vanguard Group Inc. now owns 31,762,511 shares of the real estate investment trust’s stock valued at $1,047,845,000 after buying an additional 1,397,206 shares during the period. BlackRock Inc. boosted its position in shares of Omega Healthcare Investors by 4,872.8% in the first quarter. BlackRock Inc. now owns 19,889,913 shares of the real estate investment trust’s stock valued at $656,169,000 after buying an additional 19,489,938 shares during the period. State Street Corp boosted its position in shares of Omega Healthcare Investors by 2.5% in the first quarter. State Street Corp now owns 6,020,950 shares of the real estate investment trust’s stock valued at $198,623,000 after buying an additional 147,637 shares during the period. Bank of New York Mellon Corp boosted its position in shares of Omega Healthcare Investors by 1.7% in the first quarter. Bank of New York Mellon Corp now owns 4,072,873 shares of the real estate investment trust’s stock valued at $134,365,000 after buying an additional 67,809 shares during the period. Finally, Morgan Stanley boosted its position in shares of Omega Healthcare Investors by 1.6% in the first quarter. Morgan Stanley now owns 3,687,995 shares of the real estate investment trust’s stock valued at $121,667,000 after buying an additional 59,077 shares during the period. 73.85% of the stock is owned by hedge funds and other institutional investors.
Omega Healthcare Investors, Inc. (OHI) opened at 31.06 on Monday. The firm’s 50 day moving average price is $33.09 and its 200-day moving average price is $32.66. Omega Healthcare Investors, Inc. has a one year low of $28.11 and a one year high of $38.09. The company has a market capitalization of $6.13 billion, a PE ratio of 16.39 and a beta of 0.52.
Omega Healthcare Investors (NYSE:OHI) last released its earnings results on Wednesday, July 26th. The real estate investment trust reported $0.33 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by $0.16. The company had revenue of $194 million for the quarter, compared to analyst estimates of $194.59 million. Omega Healthcare Investors had a return on equity of 8.88% and a net margin of 40.20%. The business’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period last year, the company posted $0.87 earnings per share. Equities analysts forecast that Omega Healthcare Investors, Inc. will post $1.95 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Tuesday, August 1st will be issued a dividend of $0.64 per share. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.63. This represents a $2.56 annualized dividend and a dividend yield of 8.24%. The ex-dividend date is Friday, July 28th. Omega Healthcare Investors’s dividend payout ratio is 133.33%.
Several research analysts recently commented on OHI shares. Zacks Investment Research raised Omega Healthcare Investors from a “hold” rating to a “buy” rating and set a $39.00 target price for the company in a research report on Wednesday, April 19th. BidaskClub raised Omega Healthcare Investors from a “hold” rating to a “buy” rating in a research report on Thursday, June 22nd. Vetr cut Omega Healthcare Investors from a “hold” rating to a “sell” rating and set a $32.50 target price for the company. in a research report on Monday, April 17th. Finally, Jefferies Group LLC reissued a “hold” rating and set a $33.00 price objective on shares of Omega Healthcare Investors in a report on Friday, May 12th. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company. The company has an average rating of “Hold” and an average target price of $34.67.
In other news, CFO Robert O. Stephenson sold 23,000 shares of the stock in a transaction on Wednesday, June 28th. The stock was sold at an average price of $34.58, for a total transaction of $795,340.00. Following the sale, the chief financial officer now directly owns 68,978 shares of the company’s stock, valued at approximately $2,385,259.24. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Craig R. Callen bought 15,000 shares of Omega Healthcare Investors stock in a transaction dated Friday, June 2nd. The shares were bought at an average cost of $31.40 per share, for a total transaction of $471,000.00. Following the completion of the acquisition, the director now owns 18,000 shares in the company, valued at approximately $565,200. The disclosure for this purchase can be found here. Corporate insiders own 4.54% of the company’s stock.
Omega Healthcare Investors Company Profile
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI).
Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
